These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 9376968
1. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Goodkin K, Wilkie FL, Concha M, Asthana D, Shapshak P, Douyon R, Fujimura RK, LoPiccolo C. Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968 [Abstract] [Full Text] [Related]
3. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL. APMIS Suppl; 2003 Mar; (114):1-37. PubMed ID: 14626050 [Abstract] [Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K. Verh K Acad Geneeskd Belg; 2001 Mar; 63(5):447-73. PubMed ID: 11813503 [Abstract] [Full Text] [Related]
5. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)]. Clemente-Millana L, Portellano JA. Rev Neurol; 2001 Mar; 31(12):1192-201. PubMed ID: 11205557 [Abstract] [Full Text] [Related]
6. Dementia and neurocognitive disorders due to HIV-1 infection. Ances BM, Ellis RJ. Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745 [Abstract] [Full Text] [Related]
7. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART. Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E. Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516 [Abstract] [Full Text] [Related]
9. The neuropathogenesis of AIDS. González-Scarano F, Martín-García J. Nat Rev Immunol; 2005 Jan; 5(1):69-81. PubMed ID: 15630430 [Abstract] [Full Text] [Related]
10. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG. Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180 [Abstract] [Full Text] [Related]
11. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Valle M, Price RW, Nilsson A, Heyes M, Verotta D. Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955 [Abstract] [Full Text] [Related]
12. The HIV Dementia Scale: predictive power in mild dementia and HAART. Bottiggi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR. J Neurol Sci; 2007 Sep 15; 260(1-2):11-5. PubMed ID: 17482212 [Abstract] [Full Text] [Related]
13. HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD. AIDS; 2007 Jul 11; 21(11):1415-22. PubMed ID: 17589187 [Abstract] [Full Text] [Related]
14. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center. Plummer DJ, Marcotte TD, Sample PA, Wolfson T, Heaton RK, Grant I, Freeman WR. Invest Ophthalmol Vis Sci; 1999 Feb 11; 40(2):435-42. PubMed ID: 9950603 [Abstract] [Full Text] [Related]
15. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA. Ann Neurol; 1997 Nov 11; 42(5):679-88. PubMed ID: 9392566 [Abstract] [Full Text] [Related]
16. [HIV-1 cognitive and motor syndrome]. Mussa M, Preux PM, Debrock C, Chazot-Balcon M, Melaku Z, Druet-Cabanac M, Kayembe K, Dumas M. Sante; 1997 Nov 11; 7(3):187-93. PubMed ID: 9296810 [Abstract] [Full Text] [Related]
17. [Dementia and human inmmunodeficiency virus infection]. Gray F. Rev Neurol (Paris); 1998 Nov 11; 154 Suppl 2():S91-8. PubMed ID: 9834549 [Abstract] [Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec 11; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
19. Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis. Nelson JA, Dou H, Ellison B, Uberti M, Xiong H, Anderson E, Mellon M, Gelbard HA, Boska M, Gendelman HE. J Neurosci Res; 2005 May 15; 80(4):562-75. PubMed ID: 15825192 [Abstract] [Full Text] [Related]
20. Neurobiology of HIV. Hult B, Chana G, Masliah E, Everall I. Int Rev Psychiatry; 2008 Feb 15; 20(1):3-13. PubMed ID: 18240058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]